Nico Hemmann

Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel.

Apollo Ventures Holding GmbH (Apollo Health Ventures) is an Independent Venture Capital firm founded in 2016 by Nils Regge and Alexandra Bause. The firm is headquartered in Hamburg.

Cleara Biotech BV operates as a biopharmaceutical company. It specializes in identification and specific elimination of subtypes of senescent cells with targeting age related diseases and counteracting therapy resistance in late stage cancer. The company was founded by Peter de Keizer, Marco Demaria, Tobias Madl and is headquartered in Utrecht, the Netherlands.

Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto.

High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany.

Mbiomics GmbH is a German company that specializes in microbiome analysis. The company is based in Munich, Germany. The company's patented precision technology allows for fast, quantitative, and accurate analysis of the microbiome, which creates a basis for various future clinical applications and accelerates microbiome-based therapeutics development. Mbiomics offers high-resolution measurements of the composition of the microbiome, combining DNA and RNA analysis with a highly standardized workflow and unique single/molecule detection to tackle the three key challenges in microbiome profiling. The company was founded in 2020 by Laura Figulla, Johannes B. Woehrstein, Heinrich Grabmayr, and Laura Figulla has been the CEO since 2020.

Part of Notal Vision Ltd., Notal Vision, Inc. develops ophthalmic diagnostic devices. The private company is based in Manassas, VA. The company was founded by Barak Azmon. The CEO is Kester Nahen.

Nitinotes Ltd. develops advance non-surgical bariatric solutions. The company was founded by Tamir Wolf and Irit Yaniv in 2014 and is headquartered in Ramat Gan, Israel.

RDC - Rafael Development Corp. Ltd. (RDC - Rafael Development Corp) is a private equity/venture capital subsidiary of Elron Ventures Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel.

Part of Cornhill Corp. LLP, RDC Communications Ltd. provides wireless telecommunications services. The company is based in Jerusalem, Israel. RDC Communications was acquired by Telent Technology Services Ltd. on July 01, 1999 for $39.31 million.

CartiHeal Ltd. operates as a medical device company which develops implants for the regeneration of cartilage and bone disorders. Its product includes Agili-C implant which promote regeneration of true hyaline cartilage and its subchondral bone without the use of cells, growth factors, or other exogenous agents. The company was founded by Nir Altschuler in 2009 and is headquartered in Kfar Saba, Israel.

The effectiveness of efforts of enterprises and public institutions need above-average effective IT solutions for a long-reliable network performance and security. This challenge leads directly to COMCO AG, because it thinks in terms of power projection. It opens up space for new opportunities in order to orient itself precisely to your individual needs and possibilities. And as the firm consistently use as a market-leading system and software firm Best Practices, the firm will achieve these goals for you on the direct and economical route. The COMCO AG has two complementary business units: Business Security Software and Network Solution Provider. Zum Media industry customer base includes renowned companies, banks, insurance companies, utilities, large retailers and companies from the automotive sector, state and federal authorities. COMCO The unit has made since its formation in 1998, an outstanding reputation in the market, and covers the entire range of network solutions. For this the firm offers its customers in the areas of network infrastructure, network management and IT security excellent product know-how, extensive expertise and a deep understanding of the complex relationships between business and IT processes. From advice in the planning stage through implementation to service and support of the entire IT system environment here as its services. This division is focused on the development of security solutions to protect enterprise networks against internal attacks. Hardware or internal attacks by foreign intelligence data to be reported across a network to proactively detect and prevent.

Zoll Medical Israel Ltd. develops patient monitoring solutions for chronic cardiac illnesses. It has developed a proprietary technology for the detection and monitoring of changes in fluid contents, based on a proprietary RF sensing technology. The firm’s solutions are designed to provide healthcare professionals with accurate and reliable information on the patient's clinical status for support of medical decision-making. The company was founded by y Murali Srivathsa, Uriel Weinstein, Assaf Bernstein, Michal Shohat in 2008 and is headquartered in Kfar Saba, Israel.

POCARED Diagnostics Ltd. engages in developing diseases diagnostic technologies, with the purpose of optimizing antibiotic stewardship, patient care and laboratory efficiency. Its pipeline includes rapid antimicrobial susceptibility technology. The company was founded by Jonathan Gurfinkel, and Gal Ingber in 2004 and is headquartered in Rehovot, Israel.

Galil Medical Ltd. provides cryotheraphy solutions. It offers systematic and needles way of treatment in the areas includes conditions affecting bone, kidney, liver, lung and prostate, as well as targeted pain and nerve applications. The company was founded in 1997 and is headquartered in Yokneam, Israel.

Sync-Rx Ltd. develops trans-catheter cardiovascular interventions technology solutions. It focuses on cornory angioplasty and percutaneous valve replacement and repair. The company was founded by David Tolkowsky in 2007 and is headquartered in Netanya, Israel.

NeuroSonix Ltd. develops and markets non-invasive ultrasound-based embolic protection technology and devices. Its products include EmBlocker, an ultrasonic device, which is used to deflect gaseous and solid emboli during open heart surgeries. The company was founded by Simcha Milo and Nathan Sela in 2002 and is headquartered in Rehovot, Israel.

Impliant, Inc. develops novel spine arthroplasty solutions for motion preservation. The company was founded by Amiram Steinberg and Uri Arnin in 2004 and it is headquartered in Princeton, NJ.

QuantomiX Ltd. develops and markets capsules that enable real-time analysis of wet cells and tissue biopsies. The firm with the its QXTM capsule product line, wet samples, including cells and tissues biopsies, will be able to be examined immediately and accurately. The company's technology enables scanning electron microscopes (SEM) to image and analyze wet samples such as cells, tissue biopsies, foods and ink, in their native environment. QuantomiX was founded in March 2001 by Micha Brunstein, Zachy Berger and Ory S. Zik and is headquartered in Rehovot, Israel.

Medingo Ltd. engages in developing a tiny insulin pump that allows people with diabetes to deliver insulin discreetly without tubing or injections. Medingo's product is Solo MicroPump. The company was founded on November 2, 2005 and is headquartered in Tel Aviv, Israel.

BrainsGate Ltd. develops medical devices. The firm specializes in therapies for patients suffering from central nervous system diseases. Its platform technology involves electrical stimulation of the Spheno-Palatine Ganglion, a nervous center known to increase cerebral blood flow. The company was founded by Yossi Gross and David Yarnitsky in 2000 and is headquartered in Caesarea, Israel.

MTIP AG (MTIP) is an independent private equity/venture capital firm founded in 2014. The firm is headquartered in Basel, Switzerland.